MICHAEL SCAMMAHORN: Open Payments
NPI 1285096909 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 10 payments from 4 companies in 2025. Trend: 2023 $149 · 2024 $673 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $355 |
| Otsuka America Pharmaceutical, Inc. | 2 | $214 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Alkermes, Inc. | 1 | $116 |
Products named: INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY, VIVITROL, REXULTI.
Industry payments across OK — which companies pay providers there.
